Developmental brain abnormalities and acute encephalopathy in a patient with myopathy with extrapyramidal signs secondary to pathogenic variants in MICU1
Katelynn M. Wilton,
Joel A. Morales‐Rosado,
Duygu Selcen,
Karthik Muthusamy,
Sarah Ewing,
Katherine Agre,
Katherine Nickels,
Eric W. Klee,
Mai‐Lan Ho,
Eva Morava
Affiliations
Katelynn M. Wilton
Medical Scientist Training Program, Mayo Clinic Alix College of Medicine Mayo Clinic Rochester Minnesota USA
Joel A. Morales‐Rosado
Center for Individualized Medicine Mayo Clinic Rochester Minnesota USA
Duygu Selcen
Department of Neurology Mayo Clinic Rochester Minnesota USA
Karthik Muthusamy
Department of Clinical Genomics Mayo Clinic Rochester Minnesota USA
Sarah Ewing
Department of Clinical Genomics Mayo Clinic Rochester Minnesota USA
Katherine Agre
Department of Clinical Genomics Mayo Clinic Rochester Minnesota USA
Katherine Nickels
Department of Neurology Mayo Clinic Rochester Minnesota USA
Eric W. Klee
Center for Individualized Medicine Mayo Clinic Rochester Minnesota USA
Mai‐Lan Ho
Department of Radiology Nationwide Children's Hospital Columbus Ohio USA
Eva Morava
Center for Individualized Medicine Mayo Clinic Rochester Minnesota USA
Abstract Mitochondria play a variety of roles in the cell, far beyond their widely recognized role in ATP generation. One such role is the regulation and sequestration of calcium, which is done with the help of the mitochondrial calcium uniporter (MCU) and its regulators, MICU1 and MICU2. Genetic variations in MICU1 and MICU2 have been reported to cause myopathy, developmental disability and neurological symptoms typical of mitochondrial disorders. The symptoms of MICU1/2 deficiency have generally been attributed to calcium regulation in the metabolic and biochemical roles of mitochondria. Here, we report a female child with heterozygous MICU1 variants and multiple congenital brain malformations on MRI. Specifically, she shows anterior perisylvian polymicrogyria, dysmorphic basal ganglia, and cerebellar dysplasia in addition to white matter abnormalities. These novel findings suggest that MICU1 is necessary for proper neurodevelopment through a variety of potential mechanisms, including calcium‐mediated regulation of the neuronal cytoskeleton, Miro1‐MCU complex‐mediated mitochondrial movement, or enhancing ATP production. This case provides new insight into the molecular pathogenesis of MCU dysfunction and may represent a novel diagnostic feature of calcium‐based mitochondrial disease.